Anlon Healthcare shares debuted on Wednesday with a modest premium of 1% on the NSE, which reflects a weak market sentiment in the midst of a broader volatility in the pharmaceutical sector. The IPO saw a healthy general subscription percentage of 7.12 times, with retail investors subscribing 47.26 times, non-institutional investors (NII) 10.61 times and […]
